CADILAHC Intraday Analysis...

CADILAHC Share Price

Open 442.40 Change Price %
High 445.50 1 Day 1.40 0.32
Low 437.55 1 Week 0.85 0.19
Close 443.75 1 Month -47.85 -9.73
Volume 1242241 1 Year 51.70 13.19
52 Week High 560.00
52 Week Low 328.80
CADILAHC Important Levels
Resistance 2 451.12
Resistance 1 448.08
Pivot 442.27
Support 1 439.42
Support 2 436.38
NSE INDIA Most Active Stocks
JPASSOCIAT 18.75 -2.60%
RCOM 13.60 -2.51%
BHEL 92.85 4.74%
HDIL 61.55 0.24%
PRAJIND 105.95 19.99%
SUZLON 13.60 -0.37%
JAICORPLTD 161.05 1.77%
IDEA 96.10 -2.39%
IBREALEST 212.50 -0.26%
PNB 186.50 -1.43%
More..
NSE INDIA Top Gainers Stocks
PRAJIND 105.95 19.99%
MTEDUCARE 68.60 19.93%
APTECHT 395.85 19.45%
PRECOT 101.95 19.03%
SPECIALITY 167.00 17.11%
RAJRAYON 0.35 16.67%
NAGREEKEXP 51.55 16.63%
DIAPOWER 18.45 15.67%
PITTILAM 78.35 15.39%
SIS 1032.15 14.63%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
LCCINFOTEC 0.35 -12.50%
NEULANDLAB 1133.60 -10.75%
PATSPINLTD 32.60 -9.94%
PANORAMUNI 9.35 -9.22%
COMPINFO 26.25 -7.89%
RUCHISOYA 24.75 -6.25%
QUESS 858.00 -6.17%
GLOBALVECT 184.15 -6.02%
LITL 0.80 -5.88%
More..

Cadila Healthcare Limited (NSE: CADILAHC)

CADILAHC Technical Analysis 4
As on 23rd Nov 2017 CADILAHC Share Price closed @ 443.75 and we RECOMMEND Sell for LONG-TERM with Stoploss of 460.27 & Strong Sell for SHORT-TERM with Stoploss of 482.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
CADILAHC Target for November
1st Target up-side 525.6
2nd Target up-side 541.13
3rd Target up-side 556.66
1st Target down-side 481.3
2nd Target down-side 465.77
3rd Target down-side 450.24
CADILAHC Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 34.12 Sideways
MFI (14) MFI is 47.53 Sideways
CCI (20) CCI is -89.43 Sideways
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 471.70
10 Day Avg Volume Traded -12.99 % Less then 10 Day Average Volume
CADILAHC Other Details
Segment EQ
Market Capital 40527183872.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.zyduscadila.com
CADILAHC Address
CADILAHC
Zydus Tower
Satellite Cross Roads
Ahmedabad, 380015
India
Phone: 91 79 2686 8100
Fax: 91 79 2686 2365
Interactive Technical Analysis Chart Cadila Healthcare Limited ( CADILAHC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cadila Healthcare Limited
CADILAHC Business Profile
Cadila Health is in the Pharmaceuticals sector. Cadila Laboratories was founded in 1952 by Ramanbhai Patel(1952–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Shri Indravadan Modi. The company evolved over the next four decades into one of India's established pharmaceutical companies. In 1995 the Patel and Modi families split, with the Modi family's share being moved into a new company called Cadila Pharmaceuticals Ltd. and Cadila Healthcare became the Patel family's holding company. Cadila Healthcare did its IPO on the Bombay Stock Exchange in 2000. Its stock code on the Bombay exchange is 532321. In 2001 the company acquired another Indian pharmaceutical company called German Remedies. On June 25, 2007, the company signed an agreement to acquire 100 per cent stake in Brazil's Quimica e Farmaceutica Nikkho do Brasil Ltda (Nikkho) for around 26 million dollars. In 2010, Cadila Pharmaceuticals received a prestigious Wellcome Trust Award under the new "R&D for Affordable Healthcare in India" initiative. The current market capitalisation stands at Rs 15,310.07 crore.The company has reported a consolidated sales of Rs 1746.79 crore and a Net Profit of Rs 191.57 crore for the quarter ended Sep 2013. The company management includes Pankaj R Patel - Chairman & Managing Director, Sharvil P Patel - Deputy Managing Director, Humayun Dhanrajgir - Director, Mukesh M Patel - Director, Nitin R Desai - Director, Apurva S Diwanji - Director. It is listed on the BSE with a BSE Code of 532321 and the NSE with an NSE Code of CADILAHC. Its Registered office is at "Zydus Tower", Satellite Cross Roads,,Sarkhej Gandhinagar Highway Ahmedabad,Gujarat - 380015.